Compare Suncare Traders with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -8.78% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.90
- The company has been able to generate a Return on Equity (avg) of 1.05% signifying low profitability per unit of shareholders funds
Negative results in Jun 26
With ROCE of 2.1, it has a Expensive valuation with a 0.4 Enterprise value to Capital Employed
Stock DNA
Trading & Distributors
INR 11 Cr (Micro Cap)
25,839,402,862,038,220.00
18
0.00%
0.14
0.00%
0.28
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Suncare Traders Ltd Valuation Shifts: From Expensive to Fair Amid Market Challenges
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company continues to face considerable headwinds, reflected in its steep negative returns over multiple time horizons and a strong sell rating by MarketsMOJO. This article analyses the recent valuation changes, compares key metrics with peers, and assesses the implications for investors.
Read full news article
Suncare Traders Ltd Valuation Shifts: From Expensive to Fair Amid Market Challenges
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company’s stock performance continues to lag behind broader market indices, reflecting ongoing challenges in both operational metrics and investor sentiment.
Read full news article
Suncare Traders Ltd Valuation Shifts Signal Changing Market Sentiment
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company continues to face considerable headwinds, reflected in its steep share price decline and underwhelming financial metrics compared to peers and benchmark indices.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August 2026.
07-Aug-2026 | Source : BSEPursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Friday 7th August2026. at the Registered Office of the Company and transacted the following major businesses:
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")
07-Aug-2026 | Source : BSEDisclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
07-Aug-2026 | Source : BSEPFA
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.69%)
Nilmesh Infrabuild Llp (11.78%)
69.05%
Quarterly Results Snapshot (Standalone) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Jun 2026 is -68.75% vs 500.00% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.86% vs 51.28% in Mar 2025






